NORMA TIEDGE: Open Payments
NPI 1295139244 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57 in 2 payments from 2 companies in 2025. Trend: 2023 $46 · 2024 $235 · 2025 $57
Food & beverage: $57
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Genmab U.S., Inc. | 1 | $26 |
Products named: Fabhalta, Epkinly.
Industry payments across CA — which companies pay providers there.
